How do you pay?

How to pay the least

Ask for the cash price

Adalimumab-aacf

Adalimumab-aacf is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for Adalimumab-aacf’s cash price, and one or two other pharmacies too.
  2. Adalimumab-aacf’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand name

Adalimumab-aacf, the original

Cash priceAsk the pharmacy
Ways to save on Adalimumab-aacf

The maker’s card

KabiCare Copay Program

Savings card from Fresenius Kabi

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

Sign up on kabicare.us 

Or call 1-833-522-4227.

In the maker’s words

“they may be eligible for the copay program that lowers their out-of-pocket costs to as little as $0/month for treatment with an annual maximum…”

From the maker’s offer on kabicare.us, checked November 17, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

Adalimumab-aacf is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldAsk the pharmacy

What it’s used for

What the FDA label says

Adalimumab-aacf is a tumor necrosis factor (TNF) blocker indicated for:

  • Rheumatoid Arthritis (RA): reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA.
  • Juvenile Idiopathic Arthritis (JIA): reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 2 years of age and older.
  • Psoriatic Arthritis (PsA): reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA.
  • Ankylosing Spondylitis (AS): reducing signs and symptoms in adult patients with active AS.
  • Crohn's Disease (CD): treatment of moderately to severely active Crohn's disease in adults and pediatric patients 6 years of age and older.
  • Ulcerative Colitis (UC): treatment of moderately to severely active ulcerative colitis in adult patients. Limitations of Use: Effectiveness has not been established in patients who have lost response to or were intolerant to TNF blockers.
  • Plaque Psoriasis (Ps): treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
  • Hidradenitis Suppurativa (HS): treatment of moderate to severe hidradenitis suppurativa in adult patients.
  • Uveitis (UV): treatment of non-infectious intermediate, posterior, and panuveitis in adult patients.

Source: the FDA label for Adalimumab-aacf (Fresenius Kabi USA, LLC), January 8, 2026. Full label on DailyMed 

Good to know

  • “Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
  • Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.